Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Importance of sustainable local government funding in tackling health inequalities in the UK.

Perspectives in public health·2024

Same author

Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

Can We Miniaturize CT Technology for a Successful Mobile Stroke Unit Roll-Out?

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023

Same author

Malaysia Stroke Council guide on acute stroke care service during COVID-19 Pandemic.

The Medical journal of Malaysia·2020

Same author

Divining responder populations from survival data.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Same author

Comparison of family nursing in Slovenia and Scotland: integrative review.

International nursing review·2016

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

Multidisciplinary approach to carotid stenting.

C S Mak¹, B R Chambers, D J Clark

¹National Stroke Research Institute, Australia.

Internal Medicine Journal

|June 22, 2010

Summary

This summary is machine-generated.

A multidisciplinary approach effectively supports carotid angioplasty and stenting (CAS) programs. This strategy yielded outcomes comparable to major trials, demonstrating its value in managing stroke risk.

Related Experiment Videos

Last Updated: Jun 12, 2026

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

Area of Science:

Interventional Neurology
Vascular Surgery
Cardiology

Background:

Carotid angioplasty and stenting (CAS) is increasingly adopted by specialists due to potential benefits over carotid endarterectomy (CEA).
A dedicated neuro-interventional group was established to standardize CAS indications and training.
This study aimed to evaluate the organizational model and clinical outcomes of a new CAS program.

Purpose of the Study:

To describe the organizational model of a multidisciplinary neuro-interventional group.
To assess 30-day complication rates and early outcomes of CAS.
To compare outcomes with those reported in major clinical trials.

Main Methods:

CAS was performed on patients with high medical risk for CEA or technically difficult anatomy for CEA.
Patients were also included if randomized to CAS in a clinical trial.
A clinical protocol ensured optimal patient management, with interventionists receiving proctoring in a significant number of cases.

Main Results:

47 patients underwent 50 CAS procedures between October 2003 and May 2008.
Procedural success rate was 94%.
The 30-day rate of stroke or death was 6%, and the one-year rate of stroke or death or ipsilateral stroke was 10.6%. Restenosis occurred in 13% of cases.

Conclusions:

A multidisciplinary approach is effective for establishing and maintaining a successful CAS program.
The program demonstrated comparable safety and efficacy to major CAS trials.
This model facilitates standardized care and training in complex neuro-interventional procedures.